Treatment of viral and neoplastic diseases with double-stranded RNA derivatives and other new agents
JL Ambrus Sr, KC Chadha, A Islam… - Experimental …, 2006 - journals.sagepub.com
JL Ambrus Sr, KC Chadha, A Islam, S Akhter, JL Ambrus Jr
Experimental Biology and Medicine, 2006•journals.sagepub.comMany attempts have been made to inhibit viral and neoplastic diseases by targeting the RNA
system. The pathophysiologic significance of the microRNA system and the therapeutic
potential of its manipulation are discussed. Studies of double-stranded RNA derivatives are
reviewed. The therapeutic potential of one of these compounds, polyl: MPC, is emphasized.
Studies of other related antiviral and antineoplastic agents are discussed, including 2′-
deoxyoligocytidilates and telomerase inhibitors.
system. The pathophysiologic significance of the microRNA system and the therapeutic
potential of its manipulation are discussed. Studies of double-stranded RNA derivatives are
reviewed. The therapeutic potential of one of these compounds, polyl: MPC, is emphasized.
Studies of other related antiviral and antineoplastic agents are discussed, including 2′-
deoxyoligocytidilates and telomerase inhibitors.
Many attempts have been made to inhibit viral and neoplastic diseases by targeting the RNA system. The pathophysiologic significance of the microRNA system and the therapeutic potential of its manipulation are discussed. Studies of double-stranded RNA derivatives are reviewed. The therapeutic potential of one of these compounds, polyl: MPC, is emphasized. Studies of other related antiviral and antineoplastic agents are discussed, including 2′-deoxyoligocytidilates and telomerase inhibitors.
Sage Journals